Baker Brothers Life Sciences LP's Net Worth
$1.29 Billion
Who is Baker Brothers Life Sciences LP?
Baker Brothers Life Sciences LP has an estimated net worth of $1.29 Billion. This is based on reported shares across multiple companies, which include Seagen Inc., BeiGene, Ltd., INCYTE CORP, Prelude Therapeutics Inc, XOMA Corp, Kiniksa Pharmaceuticals, Ltd., Zymeworks Inc., IGM Biosciences, Inc., Kodiak Sciences Inc., ACADIA PHARMACEUTICALS INC, IDERA PHARMACEUTICALS, INC., DBV Technologies S.A., TScan Therapeutics, Inc., Neoleukin Therapeutics, Inc., Aeglea BioTherapeutics, Inc., Talis Biomedical Corp, ALEXION PHARMACEUTICALS, INC., MADRIGAL PHARMACEUTICALS, INC., SYNAGEVA BIOPHARMA CORP, GENOMIC HEALTH INC, Mirati Therapeutics, Inc., and BIOCRYST PHARMACEUTICALS INC.
SEC CIK
Baker Brothers Life Sciences LP's CIK is 0001363364
Past Insider Trading and Trends
2016 was Baker Brothers Life Sciences LP's most active year for acquiring shares with 359 total transactions. Baker Brothers Life Sciences LP's most active month to acquire stocks was the month of April. 2019 was Baker Brothers Life Sciences LP's most active year for disposing of shares, totalling 369 transactions. Baker Brothers Life Sciences LP's most active month to dispose stocks was the month of October. 2013 saw Baker Brothers Life Sciences LP paying a total of $53,799,449,047.59 for 550,002,849 shares, this is the most they've acquired in one year. In 2013 Baker Brothers Life Sciences LP cashed out on 117,349,500 shares for a total of $49,999,570,365.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BeiGene, Ltd. (BGNE) Snapshot price: $148.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.99% | 65.36K |
—
|
—
| 252.19K |
Jun 5
| |||
Form 4
| -9.43% | -1.10M |
$180.50 | -$198,550,000.00 | 10.57M |
Nov 14
| |||
Form 4
| +38.25% | 51.69K |
—
|
—
| 186.83K |
Jun 15
| |||
Form 4
| +97.65% | 66.77K |
—
|
—
| 135.14K |
Jun 22
| |||
Form 4
| +83.93% | 31.2K |
—
|
—
| 68.37K |
Jun 16
| |||
Form 4
| -1.03% | -121.15K |
$220.50 | -$26,714,457.00 | 11.67M |
Jan 4
| |||
Form 4
| -11.53% | -1.54M |
$220.50 | -$333,295,893.00 | 11.81M |
Oct 13 - Dec 4
| |||
Form 4
| +276.32% | 14.58M |
$14.23 | $207,544,548.74 | 19.86M |
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| -35.69% | -651.49K |
—
|
—
| 1.17M |
Jun 5 - Jun 6
| |||
Form 4
| +15,636.87% | 5.81M |
$108.00 | $627,922,800.00 | 5.85M |
Aug 2
| |||
Form 4
| +0.05% | 37.16K |
—
|
—
| 79.73M |
Jun 6
| |||
Form 4
| +51.44% | 1.98M |
$101.00 | $199,999,998.00 | 5.83M |
Jan 18
| |||
Form 4
| -71.13% | -35.00K |
—
|
—
| 14.2K |
Oct 13
| |||
Form 4
| +4.79% | 176.06K |
$71.00 | $12,499,976.00 | 3.85M |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 19
| |||
Form 4
| +92.04% | 1.76M |
$32.00 | $56,335,840.00 | 3.67M |
Nov 18
| |||
Form 4
| +64.92% | 82.25M |
$10.01 | $47,654,320.28 | 208.94M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Prelude Therapeutics Inc (PRLD) Snapshot price: $2.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| +0.10% | 10.38K |
$12.85 | $133,331.60 | 10.13M |
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
| +49.15% | 9.91M |
$19.00 | $29,999,993.00 | 30.08M |
Mar 27 - Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Kiniksa Pharmaceuticals, Ltd. (KNSA) Snapshot price: $18.49
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.45% | 12.69K |
—
|
—
| 2.85M |
Jun 5
| |||
Form 4
| +0.62% | 17.49K |
—
|
—
| 2.84M |
Jun 6
| |||
Form 4
| +0.71% | 20K |
—
|
—
| 2.82M |
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| -57.03% | -170.74K |
—
|
—
| 128.66K |
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
∞
| 3M |
$18.00 | $54,000,000.00 | 3M |
Feb 9 - May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Zymeworks Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
IGM Biosciences, Inc. (IGMS) Snapshot price: $11.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.10% | 3.99K |
—
|
—
| 4.11M |
Jun 28
| |||
Form 4
| +0.10% | 3.99K |
—
|
—
| 4.1M |
Mar 29
| |||
Form 4
| +2.52% | 395.32K |
$9.09 | $3,425,568.67 | 16.07M |
Mar 26 - Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
| +0.03% | 1.11K |
—
|
—
| 3.71M |
Dec 29
| |||
Form 4
| +2.67% | 532.69K |
$6.26 | $3,431,463.82 | 20.45M |
Dec 13 - Dec 15
| |||
Form 4
| +0.03% | 1.11K |
—
|
—
| 3.17M |
Sep 29
| |||
Form 4
| +0.03% | 1.11K |
—
|
—
| 3.17M |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 4
| +0.03% | 1.11K |
—
|
—
| 3.17M |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
| +0.36% | 22.42K |
$28.14 | $641,853.82 | 6.32M |
Jan 27
| |||
Form 4
| +0.01% | 446 |
—
|
—
| 3.15M |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
| +0.01% | 446 |
—
|
—
| 3.15M |
Oct 1
| |||
Form 4
| +0.01% | 446 |
—
|
—
| 3.14M |
Jul 1
| |||
Form 4
| +0.01% | 446 |
—
|
—
| 3.14M |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
|
∞
| 3.14M |
$16.00 | $50,304,000.00 | 3.14M |
Sep 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |